Aug 2023 What Did My Patient Actually Take? An Overview of Alcohol Results
According to the National Survey on Drug Use and Health conducted in 2015, 86.4% of people over the age of...
In Practice: Clinical Insights
Aug 2023 Synthetic Cannabinoids
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of prescription or illicit...
Jun 2023 Spotlight on Potential Interactions Involving Behavioral Health & Substance Use Disorder Medications
Drug-drug and drug-food interactions (DDIs) contribute to adverse drug events (ADEs) which can range in severity from mild effects to...
Jun 2023 Polysubstance Use: Fentanyl and Stimulants
The United States is in an overdose epidemic, with the CDC estimating that 106,699 individuals died of a drug-involved overdose...
May 2023 Managing Neonatal Abstinence Syndrome: Screening and Medication Monitoring
Neonatal abstinence syndrome (NAS) affects infants who were exposed to opioids or other substances while in the womb.1 NAS has...
Mar 2023 Novel Psychoactive Substances: Newly Identified Threats Detected in the Second Half of 2022
Novel Psychoactive Substances (NPS) are a diverse group of synthetic substances created to mimic the effects of scheduled or illicit...
